• Home
  • Industry News
  • Among antidementia drugs, memantine is associated with the highest risk of pneumonia

Among antidementia drugs, memantine is associated with the highest risk of pneumonia


A recent study from the University of Eastern Finland shows that among users of antidementia drugs, persons using memantine have the highest risk of pneumonia. The use of rivastigmine patches is associated with an increased risk as well. The study found that persons using donepezil or galantamine had the lowest risk of pneumonia.

Source link